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Abstract
Glomerular filtration rate (GFR) is difficult to measure, and estimating formulas are notorious for lacking precision. This study
aims to assess if the inclusion of additional biomarkers improves the performance of eGFR formulas. A hundred and sixteen
children with renal diseases were enrolled. Data for age, weight, height, inulin clearance (iGFR), serum creatinine, cystatin C,
neutrophil gelatinase-associated lipocalin (NGAL), parathyroid hormone (PTH), albumin, and brain natriuretic peptide (BNP)
were collected. These variables were added to the revised and combined (serum creatinine and cystatin C) Schwartz formulas,
and the quadratic and combined quadratic formulas. We calculated the adjusted r-square (r2) in relation to iGFR and tested the
improvement in variance explained by means of the likelihood ratio test. The combined Schwartz and the combined quadratic
formulas yielded best results with an r2 of 0.676 and 0.730, respectively. The addition of BNP and PTH to the combined
Schwartz and quadratic formulas improved the variance slightly. NGAL and albumin failed to improve the prediction of GFR
further. These study results also confirm that the addition of cystatin C improves the performance of estimating GFR formulas, in
particular the Schwartz formula.
Conclusion: The addition of serum NGAL, BNP, PTH, and albumin to the combined Schwartz and quadratic formulas for
estimating GFR did not improve GFR prediction in our population.
What is Known:
• Estimating glomerular filtration rate (GFR) formulas include serum creatinine and/or cystatin C but lack precision when compared to measured GFR.
• The serum concentrations of some biological parameters such as neutrophil gelatinase-associated lipocalin (NGAL), parathyroid hormone (PTH),
albumin, and brain natriuretic peptide (BNP) vary with the level of renal function.
What is New:
• The addition of BNP and PTH to the combined quadratic formula improved its performance only slightly. NGAL and albumin failed to improve the
prediction of GFR further.
Keywords Glomerular filtration rate . Neutrophil gelatinase-associated lipocalin . Brain natriuretic peptide . Parathyroid
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Introduction
Estimation of glomerular filtration rate (eGFR) is important in
clinical practice [1]. Several formulas have been developed for
this purpose; however, all these formulas lack precision, and
much effort is actually made in order to improve eGFR pre-
diction. Serum creatinine (Scr) is the most commonly used
endogenous marker to estimate GFR but with relative impre-
cision owing to variation of non-GFR determinants of Scr,
e.g., muscle mass, high meat-containing diet, or tubular secre-
tion. Moreover, an increase in Scr may not be observed until a
substantial decrease of at least 40% in GFR has occurred [2].
Recently, serum cystatin C (Scyst C) has emerged as an alter-
native to or a complement of creatinine measurement in the
evaluation of kidney function. Several studies have shown a
better estimation of GFR using combined Scr and Scyst C
measurements [3, 4]. However, Scyst C can be influenced
by uncontrolled thyroid disease or immunosuppressive thera-
pies [5, 6], also leading to a decrease in eGFR precision. Until
now, measurement of inulin clearance represents the gold
standard method to assess GFR. Other exogenous markers
(i.e., Cr-51 EDTA, iohexol) have been used as well; however,
all these methods can be cumbersome and are not always
available in clinical practice [7].
To overcome the above-mentioned limitations,many serum bio-
markers have been incorporated in mathematical models in order to
improve bedside formula for GFR estimation [8, 9]. The Kidney
Disease Outcomes Quality Initiative (K/DOQI) guidelines recom-
mend estimating GFR in adults and children using Scr and/or Scyst
C based predictive equations [1]. The most widely used formula is
the Schwartz formula, which was developed in 1976 and revised in
2009 [10–12]. We have also developed a Scr and a combined (Scr
and Scyst C) quadratic formula in order to better assess GFR in
Swiss children [13, 14]. However, all these new formulas lack pre-
cisionwhen compared tomeasuredGFR.Much effort is invested in
finding new biomarkers to improve the accuracy of bedside GFR
estimation. This study aimed to evaluate if the addition of serum
neutrophil gelatinase-associated lipocalin (NGAL), brain natriuretic
peptide (BNP), parathyroid hormone (PTH), and albumin improves
the performance of the Schwartz and the quadratic formulas, com-
pared to urinary inulin clearances.
The choice of biomarkers to be included in this study was
based on several considerations. NGAL has recently emerged
as a predictive biomarker in chronic kidney disease (CKD)
[15]. PTH is a recognized biomarker in CKD. Fu et al. [16]
showed a significant negative correlation between PTH and
eGFR. In addition, Okamoto K et al. [17] demonstrated that
changes in PTH levels were associated with kidney function
and renal outcome. Regarding albumin, patients with CKD
often present with decreased appetite secondary to uremia
and consequently may develop malnutrition [9, 18]. Finally,
BNP has been used in CKD progression and GFR estimation
in adult patients [19, 20].
To the best of our knowledge, there are no adult nor pedi-
atric studies evaluating the impact of BNP, PTH, NGAL, and
albumin in estimating GFR.
Patients and methods
Patients
Children with chronic kidney diseases (CKD) who were re-
ferred to our clinic for GFR measurement between August
2012 and June 2013 were retrospectively included. Children
were aged between 3 and 18 years. Causes of CKD included
congenital and acquired single kidney, obstructive or reflux
uropathy, polycystic kidney disease, and other various diag-
noses (Bartter syndrome, patients with history of hemolytic
uremic syndrome, post-chemotherapy). Patients who were un-
able to void spontaneously were excluded from the study.
Measurements and analytic methods
GFR was measured using the gold standard method—urinary
inulin clearance (iGFR). Inulin was measured using an
AutoAnalyzer 3 system, as previously reported by our research
group [13, 14]. At the time of measuring patient’s GFR, addi-
tional data were collected: height (cm), weight (kg), Scyst C
(mg/l), Scr (mg/dl), serum blood urea nitrogen (BUN) inmmol/l,
serum NGAL (ng/ml), intact serum PTH (pg/ml), serum BNP
(pg/ml), and serum albumin (mg/l). Scyst C was measured using
the particle-enhanced nephelometric immunoassay (Siemens
Healthcare Diagnostics). Scr was analyzed using the kinetic col-
orimetric compensated Jaffe method (Roche Diagnostics, cobas
8000) which was calibrated against the enzymatic method and
standardized against the reference isotope dilution mass spec-
trometrymethod. SerumBUNwasmeasuredwith the enzymatic
assay (Roche Diagnostics, cobas 8000), and PTH was measured
with enzyme immunoassay (Immulite 2000 XPi/Siemens), BNP
with electro-chemiluminescence immunoassay (Roche
Diagnostics, cobas 8000/e801), and serum albumin with
bromocresol green (Roche Diagnostics, cobas 8000). The
eGFR was calculated with the following equations: revised
Schwartz, combined Schwartz, quadratic, and combined qua-
dratic formulas (Table 1).
Statistical analysis
Continuous data are presented as median with interquartile range
[IQR] and categorical as percentages. We used a simple linear
regression to examine association of continuous variables (age,
sex, height, serum cystatin C, creatinine, NGAL, BNP, PTH,
and albumin) with inulin clearance. We first obtained the vari-
ance in inulin clearance explained by the basic formulas, i.e., the
coefficient determination (r-squared). Then we added to the best
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fitted linear regression each of the additional variables (serum
cystatin C, NGAL, BNP, PTH, and serum albumin), one at a
time, obtained the adjusted r-square of themodels, and tested the
improvement in variance explained by means of the likelihood
ratio test. Significance was set at p < 0.05.
We attempted to construct a parsimonious multivariate
model predicting inulin clearance including all statistically
significant predictors.
Results
A total of hundred and sixteen patients were enrolled in this
study. Patients’ median [IQR] age was 12.6 [8.4–15.5] years,
and 52% were boys. Children’s demographic characteristics
are summarized in Table 2. Ninety-one percent of the patients
had CKD stage I and II, and 9% had a CKD stage III to V. All
patients’ data were well documented and recorded, without
any missing data.
Median [IQR] iGFRwas 82.5 [71.0–98.8] ml/min/1.73 m2.
The median values for eGFR using the revised and combined
Schwartz formula, the quadratic, and the combined quadratic
formula were 89.5, 91.3, 91.5, and 88.0 ml/min/1.73m2, re-
spectively. Results confirmed that the best empirical model for
inulin clearance (r2 = 0.75) was the association of sex, inverse
creatinine, inverse creatinine squared, height squared, and in-
verse cystatin C.
The combined quadratic formula performed best, with the
highest r2 value at 0.730 (Table 3) compared to other formulas
(r2 at 0.569, 0.676, and 0.708 for the Schwartz, combined
Schwartz, and quadratic formulas, respectively).
The addition of cystatin C to the Schwartz and the quadrat-
ic formulas improved r2 the most (from 0.569 and 0.708 to
0.700 and 0.734, respectively). Adding BNP and PTH also
improved the variance of the combined quadratic formula
slightly (from 0.708 to 0.738 for both, p = 0.042 and 0.046,
respectively) (Table 3). The addition of NGAL and serum
albumin did not increase r2 (Table 3).
After adding BNP and PTH to the combined Schwartz
formula, the r2 changed from 0.676 to 0.694 and 0.673, re-
spectively. Regarding the addition of NGAL and serum albu-
min the combined Schwartz formula, we observed a change of
r2 from 0.676 to 0.673 and 0.682, respectively. In neither case
were we able to specify a multivariate model that was signif-
icantly better than the basic formulas plus cystatin C.
Discussion
In this study, we found that the addition of serum NGAL,
BNP, PTH, and albumin to the combined Schwartz and qua-
dratic formulas for estimating GFR did not improve GFR
prediction in our population. This study represents a new step
in developing better GRF estimation equations with the addi-
tion of several renal biomarkers. We attempted to evaluate the
usefulness of adding BNP, PTH, NGAL, and albumin in the
estimation of GFR. BNP is a peptide hormone whose
Table 1 Equations used for the estimation of glomerular filtration rate
Revised Schwartz formula 0.413 × (Ht/Scr)
Combined Schwartz formula 39.8 × (Ht/Scr)0,456 × (1.8/Scys)0.418 × (30/BUN)0.079 × (Ht/1.4)0.179 [× 1.076 if female]
Quadratic formula 60 × (Ht/Scr) – 6.25 × (Ht/Scr)2 + 0.48 x age – [25.68 if female or 21.53 if male]
Combined quadratic formula 0.42 × (Ht/Scr) − 0.04 × (Ht/Scr)2 – 14.5 x Scys + 0.69 × age + [18.25 if female or 21.88 if male]
Glomerular filtration rate expressed in ml/min/1.73m2
Ht, height expressed in cm; Scr, serum creatinine expressed in mg/dl; Scys, serum cystatin c expressed in mg/l; BUN, blood urea nitrogen expressed in
mg/dl; age expressed in years
Table 2 Overview of the patient characteristics
Number of patients 116
Height in cm 151 [129–166]
Weight in kg 42.9 [27.2–57.6]
BMI 18 [16–21]
Renal disease
Congenital and acquired single kidney 20 (17)
Obstructive or reflux uropathy 53 (46)
Polycystic kidney disease 19 (16)
Miscellaneous 24 (21)
Inulin clearance (ml/min/1.73m2) 82.5 [71.0–92.8]
Estimated GFR (ml/min/1.73m2)
Revised Schwartz formula 89.5 [72.0–99.0]
Combined Schwartz formula 91.3 [82.1–101.4]
Quadratic formula 91.5 [78.2–98.0]
Combined Quadratic formula 88.0 [79.2–93.0]
CKD stages
Stage l 36 (31)
Stage ll 70 (61)
Stage iii 4 (3)
Stage lV and V 6 (5)
Continuous variables are presented as median with IQR and categorical
as n (%)
IQR interquartile range, BMI body mass index expressed in kg/m2 .
Miscellaneous includes the following diagnoses: Bartter syndrome, pa-
tients with history of hemolytic uremic syndrome, and post-
chemotherapy
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physiological role is regulation of intravascular blood volume
and vascular tone. Increase of BNP level may reflect renal
failure. Wiley et al. demonstrated in a cohort of 1739 adult
patients a statistically significant correlation between BNP
and eGFR using the MDRD formula [19]. Takase et al.
showed similar results in a population of 282 patients [20].
We found a positive effect of adding BNP to the combined
quadratic formula; however, the effect remains extremely
small, albeit significant. Regarding PTH, it is well known that
PTH increases with CKD progression. Several studies ana-
lyzed the correlation between PTH and GFR. This correlation
may depend on the degree of CKD [21–23]. Similar to BNP,
this study showed that adding PTH led to a slight increase in
the performance of the combined Scr and Scyst C formulas.
However, the clinical impact is limited, creating a more com-
plicated formula. In a recent study, there was a significant
correlation between serum NGAL and measured GFR in chil-
dren with CKD. The authors concluded that serum NGAL
may prove useful in the quantitation of CKD, especially at
low levels of measured GFR, where, by correlation analysis,
NGAL outperformed cystatin C [15]. In addition, Bolignano
et al. [24] demonstrated that NGAL is an independent predic-
tor of CKD progression. Despite the fact that NGAL has been
shown to be a good diagnostic and prognostic biomarker of
acute and chronic renal failure [15, 25, 26], the addition of
NGAL did not lead to a better prediction of measured GFR.
Finally, albumin has been previously used in adult GFR esti-
mation formulas [9]. Levey A et al. showed that for every 10%
of albumin change, there was a 3.1% change in GFR [9]. This
study is the first one to include albumin in eGFR pediatric
formulas. Similar to NGAL, albumin did not increase the per-
formance of combined creatinine and cystatin C GFR estima-
tion formulas. In the same vein, other researchers attempted to
develop formulas incorporating new biomarkers such as β2-
Microglobulin or β-Trace Proteins, with conflicting results
[27, 28]. Recently, Inker LA et al. nicely demonstrated that
the incorporation of β2-Microglobulin and β-Trace Protein
into adult prediction formulas improved their performance,
without incorporating the race data [29]. Chen N et al. also
showed the beneficial addition of β2-Microglobulin and β-
Trace Protein in improving GFR estimation in a Chinese pop-
ulation, however without significant clinical impact [30]. The
utility of these two biomarkers in predicting GFR should be
investigated further.
Our study results confirm that the addition of Scyst C im-
proves the performance of estimating GFR formulas, in par-
ticular the Schwartz formula. Recently, den Bakker et al. dem-
onstrated in a large cohort of 408 patients that Scr and Scyst C
were the most powerful predictors of GFR, even in the ab-
sence of height data [31]. Deng et al. confirmed a better accu-
racy and applicability of the multivariate eGFR equations in-
cluding Scr and Scyst C compared to univariate formulas [32].
The strength of this study is the use of inulin clearance. All
variables were measured simultaneously during inulin test,
therefore reducing potential variation in their level due to pro-
gression of renal failure with time. In addition, to the best of
our knowledge, this is the first study investigating the poten-
tial role of NGAL, BNP, PTH, and albumin in GFR estima-
tion in a pediatric population.
However, the study results and conclusions are limited by
the fact that we have included only Swiss children, and by a
small number of patients with iGFR < 60 ml/min/1.73m2.
These limit the generalizability of the results to non-
Caucasian children and to those with moderate to severe CKD.
In conclusion, serum creatinine and cystatin C remain the
best predictors for GFR estimation. The addition of other pa-
rameters (i.e., BNP and PTH) may be beneficial but should
balance the complexity of the new equations and its associated
cost.
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Table 3 Ability to explain
variance in iGFR of existing
eGFR formulas (adjusted r-
square), and increase after the
inclusion of additional
biomarkers in a linear regression
model
Revised Schwartz Combined Schwartz Quadratic Combined quadratic
Basic formula 0.569 0.676 0.708 0.730
+ NGAL 0.566 0.673 0.708 0.731
+ BNP 0.620 0.694 0.728 0.738
+ PTH 0.651 0.673 0.728 0.738
+ Albumin 0.608 0.682 0.717 0.731
NGAL neutrophil gelatinase-associated lipocalin, BNP brain natriuretic peptide, PTH parathyroid hormone
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